Hikma Pharmaceuticals Plc Debt to Equity Ratio 2016-2025 | HKMPF

Current and historical debt to equity ratio values for Hikma Pharmaceuticals Plc (HKMPF) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Hikma Pharmaceuticals Plc debt/equity for the three months ending June 30, 2025 was 0.33.

Hikma Pharmaceuticals Plc Debt/Equity Ratio Historical Data
Date	Long Term Debt	Shareholder's Equity	Debt to Equity Ratio
2025-06-30	$3.00B	$2.55B	1.18
2024-12-31	$2.81B	$2.32B	1.21
2024-06-30	$2.55B	$2.30B	1.11
2023-12-31	$2.47B	$2.21B	1.12
2023-06-30	$2.42B	$2.20B	1.10
2022-12-31	$2.32B	$2.15B	1.08
2021-12-31	$1.91B	$2.47B	0.77
2021-06-30	$1.88B	$2.30B	0.82
2020-12-31	$1.99B	$2.15B	0.93
2020-06-30	$2.07B	$1.90B	1.09
2019-12-31	$1.80B	$2.13B	0.85
2019-06-30	$1.76B	$1.84B	0.96
2018-12-31	$1.80B	$1.70B	1.06
2018-06-30	$1.80B	$1.54B	1.17
2017-12-31	$1.86B	$1.53B	1.22
2017-06-30	$1.94B	$2.45B	0.79
2016-12-31	$1.95B	$2.41B	0.81
2015-12-31	$1.25B	$1.35B	0.92

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$4.736B	$3.127B
Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$87.508B	33.24
Zoetis (ZTS)	United States	$52.288B	18.71
Takeda Pharmaceutical (TAK)	Japan	$45.120B	9.21
Daiichi Sankyo, - (DSNKY)	Japan	$42.092B	20.96
BeOne Medicines - (ONC)	Switzerland	$38.276B	187.73
Sandoz Group AG (SDZNY)	Switzerland	$31.588B	0.00
United Therapeutics (UTHR)	United States	$21.068B	18.54
Merck (MKKGY)	Germany	$18.081B	11.15
Neurocrine Biosciences (NBIX)	United States	$15.505B	37.20
Shionogi (SGIOY)	Japan	$14.479B	13.30
Summit Therapeutics (SMMT)	United States	$14.120B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.230B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$13.111B	0.00
IPSEN (IPSEY)	France	$11.771B	0.00
Orion OYJ (ORINY)	Finland	$9.922B	28.35
Corcept Therapeutics (CORT)	United States	$9.057B	97.85
Eisai (ESAIY)		$8.738B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.696B	37.47
Ono Pharmaceutical (OPHLF)	Japan	$6.238B	18.97
Grifols, S.A (GRFS)	Spain	$6.085B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$4.429B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$4.021B	0.00
NewAmsterdam Pharma (NAMS)	Netherlands	$3.998B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.829B	18.18
Hypermarcas (HYPMY)	Brazil	$2.971B	20.39
Dyne Therapeutics (DYN)	United States	$2.896B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.892B	9.23
Soleno Therapeutics (SLNO)	United States	$2.759B	0.00
Ocular Therapeutix (OCUL)	United States	$2.680B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.084B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.059B	24.41
Guardian Pharmacy Services (GRDN)	United States	$1.884B	36.29
Harrow (HROW)	United States	$1.694B	103.98
BioCryst Pharmaceuticals (BCRX)	United States	$1.598B	94.88
Amylyx Pharmaceuticals (AMLX)	United States	$1.559B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.514B	7.50
Oruka Therapeutics (ORKA)	United States	$1.493B	0.00
Ardelyx (ARDX)	United States	$1.453B	0.00
Relay Therapeutics (RLAY)	United States	$1.331B	0.00
Savara (SVRA)	United States	$1.323B	0.00
Enliven Therapeutics (ELVN)	United States	$1.294B	0.00
Xencor (XNCR)	United States	$1.235B	0.00
Nektar Therapeutics (NKTR)	United States	$1.157B	0.00
Evotec AG (EVO)	Germany	$1.108B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.080B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.982B	0.00
Cronos Group (CRON)	Canada	$0.953B	0.00
Theravance Biopharma (TBPH)	United States	$0.940B	39.47
Esperion Therapeutics (ESPR)	United States	$0.892B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.888B	7.93
KalVista Pharmaceuticals (KALV)	United States	$0.830B	0.00
Aquestive Therapeutics (AQST)	United States	$0.778B	0.00
ProKidney (PROK)	United States	$0.704B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.682B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.611B	0.00
Organogenesis (ORGO)	United States	$0.602B	0.00
Bioventus (BVS)	United States	$0.587B	12.02
Ironwood Pharmaceuticals (IRWD)	United States	$0.566B	13.38
Elite Pharmaceuticals (ELTP)	United States	$0.562B	0.00
Altimmune (ALT)	United States	$0.547B	0.00
Lyell Immunopharma (LYEL)	United States	$0.536B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.490B	0.00
Siga Technologies (SIGA)	United States	$0.444B	6.08
Akebia Therapeutics (AKBA)	United States	$0.409B	0.00
Nature's Sunshine Products (NATR)	United States	$0.383B	22.79
Galectin Therapeutics (GALT)	United States	$0.370B	0.00
USANA Health Sciences (USNA)	United States	$0.363B	10.14
Silence Therapeutics (SLN)	United Kingdom	$0.329B	0.00
Avalo Therapeutics (AVTX)	United States	$0.318B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.316B	0.00
Relmada Therapeutics (RLMD)	United States	$0.311B	0.00
Larimar Therapeutics (LRMR)	United States	$0.306B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.283B	0.00
OmniAb (OABI)	United States	$0.281B	0.00
Fractyl Health (GUTS)	United States	$0.280B	0.00
Pyxis Oncology (PYXS)	United States	$0.263B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.246B	0.00
Heron Therapeutics (HRTX)	United States	$0.240B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.231B	0.00
AleAnna (ANNA)	United States	$0.226B	0.00
Protara Therapeutics (TARA)	United States	$0.215B	0.00
Journey Medical (DERM)	United States	$0.215B	0.00
Profound Medical (PROF)	Canada	$0.199B	0.00
MediWound (MDWD)	Israel	$0.196B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.180B	0.00
Surrozen (SRZN)	United States	$0.175B	0.00
Innate Pharma SA (IPHYF)	France	$0.167B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.164B	0.00
Incannex Healthcare (IXHL)	Australia	$0.158B	0.00
Cassava Sciences (SAVA)	United States	$0.154B	0.00
Gain Therapeutics (GANX)	United States	$0.148B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.134B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.113B	0.00
Avita Medical (RCEL)	United States	$0.107B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.104B	0.00
Vivani Medical (VANI)	United States	$0.102B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.098B	0.00
Context Therapeutics (CNTX)	United States	$0.096B	0.00
Prelude Therapeutics (PRLD)	United States	$0.092B	0.00
Plus Therapeutics (PSTV)	United States	$0.089B	0.00
VAXART, INC (VXRT)	United States	$0.087B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.084B	0.00
Champions Oncology (CSBR)	United States	$0.083B	30.20
Acrivon Therapeutics (ACRV)	United States	$0.075B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.071B	0.00
Metagenomi (MGX)	United States	$0.067B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.066B	0.00
Korro Bio (KRRO)	United States	$0.066B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.063B	0.00
PolyPid (PYPD)	Israel	$0.063B	0.00
Dominari Holdings (DOMH)	United States	$0.062B	0.00
Arch Biopartners (ACHFF)	Canada	$0.062B	0.00
Lite Strategy (LITS)	United States	$0.061B	0.00
Nutriband (NTRB)	United States	$0.058B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
Talphera (TLPH)	United States	$0.057B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.057B	0.00
Wellgistics Health (WGRX)	United States	$0.051B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.047B	0.00
Century Therapeutics (IPSC)	United States	$0.046B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.039B	0.00
ElectroCore (ECOR)	United States	$0.039B	0.00
Klotho Neurosciences (KLTO)	United States	$0.036B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.036B	29.88
Mural Oncology (MURA)	Ireland	$0.035B	0.00
FibroGen (FGEN)	United States	$0.034B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.029B	0.00
Vyome Holdings (HIND)	United States	$0.028B	0.00
Inotiv (NOTV)	United States	$0.028B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.025B	0.00
Scienture Holdings (SCNX)	United States	$0.025B	0.00
Liminatus Pharma (LIMN)	United States	$0.023B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.022B	0.00
Natural Alternatives (NAII)	United States	$0.021B	0.00
TherapeuticsMD (TXMD)	United States	$0.020B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.020B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Mannatech (MTEX)	United States	$0.018B	0.00
Traws Pharma (TRAW)	United States	$0.018B	0.02
Lipocine (LPCN)	United States	$0.017B	0.00
Cosmos Health (COSM)	United States	$0.016B	0.00
Heatwurx (PCSA)	United States	$0.016B	0.00
Mangoceuticals (MGRX)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.015B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.014B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.012B	0.00
VYNE Therapeutics (VYNE)	United States	$0.012B	0.00
BioVie (BIVI)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Ainos (AIMD)	United States	$0.012B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Aptorum Group (APM)	United Kingdom	$0.008B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.008B	0.00
Nuvilex (PMCB)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Lyra Therapeutics (LYRA)	United States	$0.008B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.007B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
ProPhase Labs (PRPH)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Jaguar Animal Health (JAGX)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
CDT Equity (CDT)	United States	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.002B	0.00
Aditxt (ADTX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Indivior (INDV)	United States	$0.000B	17.92
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Minerva Neurosciences (NERV)	United States	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00